Interestingly, ROR1 or ROR2 upregulation has been observed in many cancers: ROR1 is upregulated in solid tumors or hematologic malignancies while ROR2 is overexpressed in osteosarcomas or renal cell carcinomas (Rebagay et al., 2012). This evidence concerns the gene ROR2 and osteosarcoma.